Atlas Trials

Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia

Clinical trial NCT06367673 · RECRUITING

Trial details

NCT number
NCT06367673
Sponsor
Zhejiang University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
AML, Adult
Start date
2024-04-30
Primary completion
2026-03-31
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.